The acquired immune deficiency syndrome (AIDS) is defined as a defect in cell-mediated immunity occurring in previously healthy individuals which is associated with multiple opportunistic infections with or without Kaposi's sarcoma.' A subgroup of these patients have secondary and life threatening CNS toxoplasmosis.2 Between January 1981 and January 1983, 90 AIDS patients were diagnosed at Kings County Hospital-Downstate Medical Center (KCH-DMC). Eighteen of these patients had CNS involvement. This report summarises the clinical, pathological and radiographic features of 12 of these 18 patients who had CNS toxoplasmosis.
Patients and methods
Of these 12 patients, six were Haitian, three IV 4, 5, 9, 11 table 2) systemic manifestations. Serologic studies for toxoplasma were positive in all of 9 patients. In two patients who had recurrence of toxoplasma, titres remained elevated. Serum Sabin-Feldman dye titres of > 1:6400 (normal < 1:100) were present in all three patients in whom this test was performed, and CSF titres were elevated in two of these three patients (table 3) . Enzymelinked immunoabsorbent assay for Toxoplasma gondii antibody in human serum (toxo-elisa) studies were abnormal in all seven patients in whom this test was performed, but were negative in two CSF examinations performed in four of these patients. Serum immunofluorescent antibody (IFA) was abnormal in all six patients and CSF IFA was abnormal in two of four patients in whom these tests were performed.
CT Four cases ofcerebral toxoplasmosis came to necropsy. In three, there were 2-4 cm necrotising granulomas, with very thin capsules and scanty inflammatory response (fig 3) . Toxoplasma organisms in cysts were present in areas of inflammation. Two cases demonstrated confluent cystic lesions, as well as necrotic masses. In one case, granulomas were not found, but there was an area of vasculitis in cerebellar white matter, with toxoplasma organisms in adjacent tissue.
Electron microscopic examination of surgical specimens showed typical toxoplasma organisms. These were characterised by double membranes, centrally placed nuclei, and conoid structures with rhophtries (fig 4) .
Clinical course
The clinical course in all 12 patients was complicated by multiple systemic infections occurring before, after, or concomitant with the onset of clinical neurological signs. Lethargy was noted in every patient, which progressed to stupor, coma and death in eight patients. In the other four patients, lethargy decreased with treatment but recurred and was followed by coma and death (table 4). Two patients (nos 2, 3) who presented with neurological deficits demonstrated complete clinical recovery following surgical removal of the lesions and treatment with pyrimethamine (25 mg/day) and sulfadiazine (6-8 mg/day) for 6 weeks. Both patients were readmitted within a month after the course of antibiotic treatment was completed because of recurrence of clinical Sabin-Feldman Dye test, and toxoelisa titre) were invariably elevated. However, these studies were often negative in the CSF.
All 12 patients succumbed within 1 1/2 years ofdiagnosis, 10 in less than 5 months. Surgical resection and a 6 week course of sulfadiazine and pyrimethamine was followed by multiple new lesions within 4-8 weeks in two of our patients. Toxicity to sulfadiazine was not seen. The syndrome of inappropriate secretion of antidiuretic hormone (SIADH) was diagnosed in three patients, and was presumably caused by intrac'erebral lesions. Accordingly, serum and urinary electrolytes should be carefully monitored in these patients. The use of long term sulfadiazine and pyrimethamine is thought to be useful in these patients. '5 16 This treatment resulted in remission in two of our patients until other opportunistic infections supervened.
The relentlessly progressive nature of AIDS in our small patient group is consistent with the uniform mortality noted in national surveys. 7 Although brain biopsy is recommended2 to insure a correct and prompt diagnosis, neither subsequent surgical nor pharmacological intervention is effective over a 1-2 year period. This is consistent with the markedly reduced degree of cellular inflammation noted in some of our pathological specimens. Clinically silent lesions may be more therapeutically susceptible if detected earlier. Therefore early baseline cerebral CT screens of neurologically normal AIDS patients may be beneficial.
